1327 Jones Drive
Email: sales @ genomenon.com
About GenomenonGenomenon develops software tools to rapidly and autonomously prioritize data points for decision-making, revolutionizing the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians and researchers to quickly, and accurately, identify disease-causing variants from genomic-sequencing datasets.
CEO: Mike Klein
Co-Founder and CSO: Mark J. Kiel MD, PhD
Co-Founder and CTO: Steve Schwartz
Co-Founder: Kojo S.J. Elenitoba-Johnson MD
Co-Founder: Megan S. Lim MD, PhD
Please click here for Genomenon's job opportunities.
Please click here for Genomenon's products.
4 articles with Genomenon
Investments from Merck KGaA, Beacon Pharmaceuticals and Genomenon will provide new jobs for local economies.